526 related articles for article (PubMed ID: 1712077)
1. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase.
Bredt DS; Hwang PM; Glatt CE; Lowenstein C; Reed RR; Snyder SH
Nature; 1991 Jun; 351(6329):714-8. PubMed ID: 1712077
[TBL] [Abstract][Full Text] [Related]
2. Interflavin one-electron transfer in the inducible nitric oxide synthase reductase domain and NADPH-cytochrome P450 reductase.
Yamamoto K; Kimura S; Shiro Y; Iyanagi T
Arch Biochem Biophys; 2005 Aug; 440(1):65-78. PubMed ID: 16009330
[TBL] [Abstract][Full Text] [Related]
3. Characterization of C415 mutants of neuronal nitric oxide synthase.
Richards MK; Clague MJ; Marletta MA
Biochemistry; 1996 Jun; 35(24):7772-80. PubMed ID: 8672477
[TBL] [Abstract][Full Text] [Related]
4. Stopped-flow kinetic studies of electron transfer in the reductase domain of neuronal nitric oxide synthase: re-evaluation of the kinetic mechanism reveals new enzyme intermediates and variation with cytochrome P450 reductase.
Knight K; Scrutton NS
Biochem J; 2002 Oct; 367(Pt 1):19-30. PubMed ID: 12079493
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the FAD binding domain of cytochrome P450 reductase.
Hodgson AV; Strobel HW
Arch Biochem Biophys; 1996 Jan; 325(1):99-106. PubMed ID: 8554349
[TBL] [Abstract][Full Text] [Related]
6. Electron transfer in flavocytochrome P450 BM3: kinetics of flavin reduction and oxidation, the role of cysteine 999, and relationships with mammalian cytochrome P450 reductase.
Roitel O; Scrutton NS; Munro AW
Biochemistry; 2003 Sep; 42(36):10809-21. PubMed ID: 12962506
[TBL] [Abstract][Full Text] [Related]
7. Brain nitric oxide synthase is a biopterin- and flavin-containing multi-functional oxido-reductase.
Mayer B; John M; Heinzel B; Werner ER; Wachter H; Schultz G; Böhme E
FEBS Lett; 1991 Aug; 288(1-2):187-91. PubMed ID: 1715290
[TBL] [Abstract][Full Text] [Related]
8. Crystallization and preliminary X-ray diffraction studies of human cytochrome P450 reductase.
Zhao Q; Smith G; Modi S; Paine M; Wolf RC; Tew D; Lian LY; Primrose WU; Roberts GC; Driessen HP
J Struct Biol; 1996; 116(2):320-5. PubMed ID: 8812989
[TBL] [Abstract][Full Text] [Related]
9. Reductase domain of Drosophila melanogaster nitric-oxide synthase: redox transformations, regulation, and similarity to mammalian homologues.
Ray SS; Sengupta R; Tiso M; Haque MM; Sahoo R; Konas DW; Aulak K; Regulski M; Tully T; Stuehr DJ; Ghosh S
Biochemistry; 2007 Oct; 46(42):11865-73. PubMed ID: 17900149
[TBL] [Abstract][Full Text] [Related]
10. Versatile regulation of neuronal nitric oxide synthase by specific regions of its C-terminal tail.
Tiso M; Tejero J; Panda K; Aulak KS; Stuehr DJ
Biochemistry; 2007 Dec; 46(50):14418-28. PubMed ID: 18020458
[TBL] [Abstract][Full Text] [Related]
11. [Nitric oxide synthase, typical flavohemoproteins and their complicated enzymology].
Jáchymová M; Masters BS; Horký K; Zima T; Martásek P
Cas Lek Cesk; 2006; 145(7):526-31. PubMed ID: 16921779
[TBL] [Abstract][Full Text] [Related]
12. An appraisal of multiple NADPH binding-site models proposed for cytochrome P450 reductase, NO synthase, and related diflavin reductase systems.
Daff S
Biochemistry; 2004 Apr; 43(13):3929-32. PubMed ID: 15049700
[TBL] [Abstract][Full Text] [Related]
13. Four crystal structures of the 60 kDa flavoprotein monomer of the sulfite reductase indicate a disordered flavodoxin-like module.
Gruez A; Pignol D; Zeghouf M; Covès J; Fontecave M; Ferrer JL; Fontecilla-Camps JC
J Mol Biol; 2000 May; 299(1):199-212. PubMed ID: 10860732
[TBL] [Abstract][Full Text] [Related]
14. Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme.
Lowenstein CJ; Glatt CS; Bredt DS; Snyder SH
Proc Natl Acad Sci U S A; 1992 Aug; 89(15):6711-5. PubMed ID: 1379716
[TBL] [Abstract][Full Text] [Related]
15. NADPH-cytochrome P-450 oxidoreductase: flavin mononucleotide and flavin adenine dinucleotide domains evolved from different flavoproteins.
Porter TD; Kasper CB
Biochemistry; 1986 Apr; 25(7):1682-7. PubMed ID: 3085707
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide synthase-catalyzed activation of oxygen and reduction of cytochromes: reaction mechanisms and possible physiological implications.
Mayer B; Heinzel B; Klatt P; John M; Schmidt K; Böhme E
J Cardiovasc Pharmacol; 1992; 20 Suppl 12():S54-6. PubMed ID: 1282986
[TBL] [Abstract][Full Text] [Related]
17. NADPH-cytochrome P-450 oxidoreductase gene organization correlates with structural domains of the protein.
Porter TD; Beck TW; Kasper CB
Biochemistry; 1990 Oct; 29(42):9814-8. PubMed ID: 2125483
[TBL] [Abstract][Full Text] [Related]
18. Importance of the domain-domain interface to the catalytic action of the NO synthase reductase domain.
Welland A; Garnaud PE; Kitamura M; Miles CS; Daff S
Biochemistry; 2008 Sep; 47(37):9771-80. PubMed ID: 18717591
[TBL] [Abstract][Full Text] [Related]
19. Purification of insoluble nitric oxide synthase from rat cerebellum.
Hiki K; Hattori R; Kawai C; Yui Y
J Biochem; 1992 May; 111(5):556-8. PubMed ID: 1379222
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of NAD(P)H:flavin oxidoreductase from Escherichia coli.
Ingelman M; Ramaswamy S; Nivière V; Fontecave M; Eklund H
Biochemistry; 1999 Jun; 38(22):7040-9. PubMed ID: 10353815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
